Walmart has reached a settlement with the U.S. Department of Justice regarding its role in facilitating opioid prescription distribution across the nation. The resolution addresses allegations that the retail giant's pharmacy operations contributed to the escalating public health crisis by filling controlled substance prescriptions without adequate safeguards. This settlement represents a significant accountability measure in ongoing efforts to combat prescription drug abuse and hold major retailers responsible for their pharmaceutical distribution practices.

Summary auto-generated by AI from the original publisher's content. Editorial standards.